Clinical Pharmacology

Clinical Pharmacology Seminar CME / CPD 

Full Course:  20 AMA PRA Category 1 Credits for CME / CEU / CPD

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:  Family Practitioners, Pediatricians, Internists, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)

Series 9 (CP9) Topics Include:  Treating Alcohol Withdrawal, Strains of Cannabis, Systemic Therapies for Prostate Cancer, Fixed-Dose Combination Drugs, Spinal Sarcomas, and more.

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Full Course:
CP9
Full Course Price:
$580
Short Course:
CP9A, CP9B
Short Course Price:
$485
Format:
Available in Audio format.

Course Topics

Toxicology 2019

Identify the advantages and disadvantages of phenobarbital and benzodiazepines to treat alcohol withdrawal; Use an algorithm to administer phenobarbital as first-line treatment of alcohol withdrawal; Determine the cause of anion gap metabolic acidosis; Elaborate on the characteristics of common drugs of abuse; Recognize key features in the presentation of patients with drug overdose that suggest nonopioid etiologies.

QUALIFIES FOR CLINICAL PHARMACOLOGY
QUALIFIES FOR SUBSTANCE ABUSE-SA092

History of Pediatric Leukemia: Diagnosis and Treatment

Summarize epidemiology, clinical presentation, and predisposing conditions associated with ALL in pediatric patients; Predict the risk for relapse of pediatric ALL based on patient age, white blood cell count, and minimal residual disease status after induction therapy; Discuss cytogenetic features of pediatric ALL and their association with disease prognosis; Describe how chimeric antigen receptor-T cell therapy may be effective for treating patients with ALL who relapse after chemotherapy and stem cell transplant; Manage the long-term effects of chemotherapy, radiation therapy, surgery, and stem cell transplant in survivors of pediatric cancer.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Treatment Options for Chronic Pain

Differentiate the properties of different strains of cannabis; Assess the evidence for the use of cannabis to treat chronic pain; Determine whether a patient is a candidate for the use of cannabis to relieve chronic pain; Elaborate on central sensitization and its implications for the diagnosis and treatment of chronic pain; Recommend a multidisciplinary approach for the management of chronic pain.

QUALIFIES FOR CLINICAL PHARMACOLOGY
QUALIFIES FOR PAIN MANAGEMENT-PM166

Insulin Update

Determine the appropriate initial doses and titration schedules when converting patients to different insulin therapies; Identify patients who may benefit from ultralong-acting basal insulin products; Counsel patients about the advantages and limitations of fixed-ratio combination therapies; Personalize insulin regimens to meet patients' needs and address therapeutic challenges.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Update on Prostate Cancer

Optimize the use of cryotherapy to treat prostate cancer; Reduce the risk for complications of cryotherapy in patients with prostate cancer; Assess the findings of studies comparing radical prostatectomy with observation, watchful waiting, or active monitoring; Evaluate the safety and efficacy of systemic therapies for prostate cancer based on recent studies; Recognize the biologic characteristics of prostate cancer and their association with the development of metastases and response to therapies.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Tailoring Treatment to Patients with Bipolar Disorder

Explain the significance of mediators and moderators of treatment in patients with bipolar disorder; Select medications for different types of patients with bipolar disorder; List some important moderators of outcomes in patients with bipolar disorder; Consider comorbidities and drug interactions when prescribing for patients with bipolar disorder; Manage a patient with bipolar disorder who is misusing alcohol.

QUALIFIES FOR CLINICAL PHARMACOLOGY

A Postgraduate Course Workshop on New Medications: Which to Use and When?

Develop strategies for the management of diabetes in patients at risk for cardiovascular events; Help patients recognize and manage adverse effects of antidiabetic agents; Provide training on the use and administration of injectable medications; Identify patients who may benefit from fixed-dose combination drugs.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Nonalcoholic Steatohepatitis (NASH)/Antibiotics

Evaluate patients with suspected nonalcoholic steatohepatitis; Consider the role of weight loss and bariatric surgery for patients with nonalcoholic steatohepatitis; Determine the role of medications in the treatment of nonalcoholic steatohepatitis; Recognize the deleterious effects of unnecessary use of antibiotics; Formulate treatment plans for patients with upper respiratory infection.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Update on Abdominal Sarcomas

Recognize differences in locoregional recurrence, distant metastasis, and survival according to histologic subtype of retroperitoneal sarcoma; Select appropriate strategies for primary surgery of retroperitoneal sarcoma on the basis of tumor histology and anatomic location; Explain the role of radiation therapy in the treatment of retroperitoneal sarcoma; Evaluate patients with recurrent retroperitoneal sarcoma to determine surgical candidacy; Summarize ways to improve clinical trial design to evaluate responses to therapy in patients with different subtypes of sarcoma.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Sarcomas and Metastasis of the Spine/ Pediatric Musculoskeletal Oncology

Use classification systems to determine optimal strategies for surgical management or palliative care of primary and metastatic spinal sarcomas; Develop multidisciplinary approaches for management of primary and metastatic spinal sarcomas; Evaluate neurologic function, oncologic status, mechanical status, and systemic disease to determine optimal management for patients with metastatic spinal sarcomas; Compare rates of local disease, distant metastasis, and overall survival between pediatric and adult patients with sarcoma; Recognize differences in treatment protocols and side effects between pediatric and adult patients with sarcoma.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include: Alternative Medicine, Family Practice and Psychiatry

If you have taken the current Clinical Pharmacology CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon.  There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.

 

Specialty

Interactive Courses